|
|
Wednesday, June 16, 2010
|
|
Time
|
Hall COSMOS
|
|
14:00-19:00
|
Registration
|
|
15:00-16:30
|
EADO Board meeting (Cronos)
|
|
16:30-18:30
|
Pre-Congress Session: Advances in therapeutics: new studies, new agents
|
|
19:00-19:30
|
Opening Ceremony
|
|
19:30-20:00
|
Opening Keynote Lecture: Molecular classification of melanocytic neoplasia
B. Bastian
|
|
20:00
|
Welcome Reception
|
|
Thursday, June 17, 2010
|
|
Time
|
Hall COSMOS
|
Hall ATLAS A
|
Hall IRIS
|
|
08:00-09:30
|
Plenary Session I: Primary prevention of melanoma: are we making progress?
|
|
|
|
09:30-10:00
|
Keynote address I: Personalizing melanoma medicine in the molecular era
Ch. Tsao
|
|
|
|
10:00-10:30
|
Break
|
|
10:30-12:00
|
Plenary Session II: Optimizing secondary prevention of melanoma
|
|
|
|
12:15-13:45
|
Lunch session I:
Sun protection and melanoma (Sponsored by Johnson & Johnson)
|
|
|
|
14:00-15:30
|
Concurrent Symposium I: Melanoma Genetics
|
Concurrent Symposium II: Imaging techniques in melanoma diagnosis and management
|
Free Communications I: Epidemiology, pathogenesis and diagnosis of melanoma
|
|
15:30-16:00
|
Break
|
|
16:00-17:30
|
Satellite Symposium I: What's new in melanoma?(Organized by Merck)
|
|
|
|
17:30-19:00
|
Plenary Session III: Evolving issues on melanoma staging and management
|
|
|
|
Friday, June 18, 2010
|
|
Time
|
Hall COSMOS
|
Hall ATLAS A
|
Hall IRIS
|
|
08:00-09:30
|
Plenary Session IV:
Current status of adjuvant therapy in melanoma
|
|
|
|
09:30-10:00
|
Keynote address II: Targeted treatment modalities for skin cancer
A. Hauschild
|
|
|
|
10:00-10:30
|
Break
|
|
10:30-12:00
|
Satellite Symposium II: Novel immunotherapeutic approaches in advanced melanoma (Organized by Bristol-Myers Squibb)
|
|
|
|
12:15-13:45
|
Lunch session II:
New treatment approaches in actinic keratoses and NMSC (Sponsored by Almirall)
|
|
|
|
14:00-15:30
|
Concurrent Symposium III: Novel strategies in melanoma immunotherapy
|
Concurrent Symposium IV: Melanoma-skin cancer screening
|
Free Communications II: Prognostic assessment and therapeutic approaches in melanoma
|
|
15:30-16:00
|
Break
|
|
16:00-17:30
|
Satellite Symposium III: Adjuvant melanoma therapy - Towards a tailored solution for the patient (Organized by GlaxoSmithKline)
|
|
|
|
17:30-19:15
|
Plenary Session V: Advances in the treatment of metastatic melanoma: from chemotherapy to targeted treatments
|
Satellite Symposium of the European Skin Cancer Foundation
(17:30-18:30)
|
|
|
Saturday, June 19, 2010
|
|
Time
|
Hall COSMOS
|
Hall ATLAS A
|
Hall IRIS
|
|
08:30-10:00
|
Concurrent Symposium V: Cutaneous T-cell lymphoma: how to diagnose and how to manage?
|
Advanced Dermatoscopy
Course
09:00-16:00
|
Concurrent Symposium VI:
Skin cancer in transplant patients
|
|
10:00-10:30
|
Break
|
Break
|
|
10:30-12:15
|
Plenary Session VI: Epidemiology and pathogenesis of NMSC (Sponsored by Alapis)
|
Free Communications III: Epidemiology and clinical management of NMSCs
|
|
12:30-14:00
|
Lunch Session III: Diagnosing and managing cutaneous toxicities of molecularly targeted therapies in cancer (Sponsored by Pierre Fabre)
|
|
|
14:15-16:15
|
Closing Session:
Clinical and therapeutic challenges in cutaneous oncology
|
|
|
16:15
|
Closing Ceremony
|
|
|
|
|
Print 
